Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
General Information
Revision date
2005-12-20
Product name
VALIUM(R) Tablets (5 mg)
CAS No.
9005-25-8
1.2.1 Relevant identified uses
- Valium is an anti-anxiety (sedative) agent
Icons in SDS
Company Information
company name
Hoffmann-La Roche Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Form tablets Color yellow Hazard Overview - Causes central nervous system depression.
Potential health effects
Exposure: Ingestion - Target Organs: skin, kidneys, liver, respiratory tract, Central nervous system - Acute Effects: May cause allergic reactions., May cause central nervous system effects., Signs and symptoms may include headache, dizziness, drowsiness, fatigue and lack of muscular coordination., Causes central nervous system depression., May cause hepatic (liver) system effects., Signs and symptoms may include elevation of liver enzyme levels and jaundice (yellowing of the skin and eyes)., May cause renal (kidney) system effects., Signs and symptoms may include urine retention, increase or decrease in urine production, painful urination and presence of blood in urine., May cause respiratory effects., Signs and symptoms may include difficulty in breathing, coughing, wheezing, irritation (inflammation) and respiratory arrest.
Potential chronic health
May cause confusion and disorientation., May cause hallucinations. - Carcinogenicity: formulation not listed by NTP, IARC or OSHA Additional Health Information - Conditions Aggravated: Hypersensitivity to this material and other materials in its chemical class. Acute narrow angle glaucoma. Respiratory system conditions. - This material may cause impairment of mental and/or physical abilities which are required to perform hazardous tasks, such as operating machinery or driving a motor vehicle. - Reproductive Toxicity: An increased risk of congenital malformations associated with the use of minor tranquilizers, such as diazepam and chlordiazepoxide, during the first trimester of pregnancy has been suggested. *1 - The placental transfer of this material in humans has been documented. *1 - Since this material may affect the developing fetus, females planning to have a child and pregnant women should exercise caution regarding exposure. *1 - It is also advisable for nursing mothers to exercise caution regarding exposure. *1 referring to: Diazepam